News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,690 Results
Type
Article (42336)
Company Profile (436)
Press Release (671918)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (208759)
Career Advice (2025)
Deals (36010)
Drug Delivery (104)
Drug Development (83583)
Employer Resources (174)
FDA (16433)
Job Trends (15098)
News (352828)
Policy (33086)
Tag
Academia (2647)
Accelerated approval (6)
Adcomms (24)
Allergies (87)
Alliances (50967)
ALS (94)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (139)
Approvals (16424)
Artificial intelligence (268)
Autoimmune disease (25)
Automation (16)
Bankruptcy (372)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (330)
Bladder cancer (82)
Brain cancer (27)
Breast cancer (287)
Cancer (2318)
Cardiovascular disease (186)
Career advice (1693)
Career pathing (30)
CAR-T (157)
Cell therapy (444)
Cervical cancer (19)
Clinical research (67782)
Collaboration (877)
Compensation (537)
Complete response letters (24)
COVID-19 (2648)
CRISPR (45)
C-suite (253)
Cystic fibrosis (105)
Data (2234)
Decentralized trials (2)
Denatured (28)
Depression (50)
Diabetes (275)
Diagnostics (6429)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (100)
Earnings (87857)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (115959)
Executive appointments (743)
FDA (17707)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (783)
Gene editing (113)
Generative AI (20)
Gene therapy (328)
GLP-1 (747)
Government (4504)
Grass and pollen (4)
Guidances (62)
Healthcare (19148)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (130)
Indications (30)
Infectious disease (2793)
Inflammatory bowel disease (143)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (98)
Interviews (314)
IPO (16790)
IRA (43)
Job creations (3701)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (496)
Leadership (18)
Legal (7986)
Liver cancer (76)
Lung cancer (328)
Lymphoma (156)
Machine learning (7)
Management (59)
Manufacturing (313)
MASH (69)
Medical device (13527)
Medtech (13532)
Mergers & acquisitions (19759)
Metabolic disorders (718)
Multiple sclerosis (82)
NASH (19)
Neurodegenerative disease (102)
Neuropsychiatric disorders (33)
Neuroscience (2002)
NextGen: Class of 2025 (6757)
Non-profit (4551)
Now hiring (39)
Obesity (385)
Opinion (223)
Ovarian cancer (77)
Pain (90)
Pancreatic cancer (84)
Parkinson's disease (155)
Partnered (21)
Patents (236)
Patient recruitment (111)
Peanut (47)
People (58687)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21298)
Phase II (29909)
Phase III (22115)
Pipeline (1216)
Policy (146)
Postmarket research (2601)
Preclinical (9138)
Press Release (67)
Prostate cancer (110)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (404)
Real estate (6015)
Recruiting (66)
Regulatory (22746)
Reports (46)
Research institute (2417)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (76)
Series A (139)
Series B (90)
Service/supplier (11)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3762)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (39)
The Weekly (48)
Vaccines (705)
Venture capitalists (43)
Weight loss (255)
Women's health (37)
Worklife (17)
Date
Today (177)
Last 7 days (888)
Last 30 days (2720)
Last 365 days (33869)
2025 (10940)
2024 (36301)
2023 (41015)
2022 (52276)
2021 (56769)
2020 (54924)
2019 (47421)
2018 (35703)
2017 (33025)
2016 (32349)
2015 (38397)
2014 (32187)
2013 (27109)
2012 (29220)
2011 (29865)
2010 (27993)
Location
Africa (736)
Alabama (58)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (39262)
Australia (6532)
California (6250)
Canada (2023)
China (535)
Colorado (272)
Connecticut (288)
Delaware (149)
Europe (85806)
Florida (914)
Georgia (207)
Idaho (57)
Illinois (553)
India (25)
Indiana (310)
Iowa (12)
Japan (163)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (910)
Massachusetts (4748)
Michigan (222)
Minnesota (397)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (67)
New Jersey (1761)
New Mexico (30)
New York (1762)
North Carolina (1034)
North Dakota (8)
Northern California (2706)
Ohio (206)
Oklahoma (14)
Oregon (38)
Pennsylvania (1391)
Puerto Rico (12)
Rhode Island (34)
South America (1110)
South Carolina (22)
South Dakota (1)
Southern California (2333)
Tennessee (101)
Texas (924)
United States (23672)
Utah (183)
Virginia (149)
Washington D.C. (63)
Washington State (574)
West Virginia (3)
Wisconsin (55)
714,690 Results for "viewpoint therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Centerline Biomedical celebrates first on-label surgical case at the University of Virginia Health System with the 6Fr Viewpoint™ Catheter
November 20, 2024
·
2 min read
Business
Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnology
Defence Therapeutics Inc. (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint with Dennis Quaid.
July 5, 2023
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Defence’s Innovative Therapeutics Featured on Viewpoint with Dennis Quaid
Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines
September 5, 2023
·
4 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
BioMidwest
Viewpoint Molecular Targeting Announces First Neuroendocrine Tumor Patients Dosed with Therapeutic Intent
Viewpoint Molecular Targeting®, Inc., a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents, today announced the first dosing of two neuroendocrine tumor patients with therapeutic intent.
January 23, 2023
·
3 min read
Press Releases
Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
April 30, 2025
·
8 min read
Deals
Visus Therapeutics Expands Ophthalmic Drug Development Portfolio With Acquisition of ViewPoint Therapeutics’ Assets
Visus Therapeutics Inc. today announced it has expanded its pipeline via the acquisition of all patents and other assets of ViewPoint Therapeutics.
September 28, 2022
·
4 min read
Press Releases
TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering
March 26, 2025
·
4 min read
Press Releases
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
April 9, 2025
·
6 min read
1 of 71,469
Next
